Arkolith/Insider Trading/LXEO/Form 4

Cholmondeley Paula H

DirectorLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4 · filed Nov 26, 2024
Net Buying
Open-Market Buys
$105K
Open-Market Sells
$0
Net Open-Market Flow
$105K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2024Buy(P)15K$6.99$105K31K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-027746) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML